Status:
UNKNOWN
RhEGF Incorporated in An Absorbable Collagen Membrane for The Management Of Gingival Recession Defects
Lead Sponsor:
SVS Institute of Dental Sciences
Conditions:
Periodontitis
Eligibility:
All Genders
20-55 years
Phase:
PHASE1
Brief Summary
A sulcular incision will be made through each recession area and the tissues will be gradually undermined including the base of the interdental papilla. At the recession sites rhEGF incorporated absor...
Detailed Description
IN TEST SITE : Local anesthesia will be administered and Vertical incisions will be given at interdental papillae away from recession defect site and a pouch will be created. A sulcular incision will...
Eligibility Criteria
Inclusion
- Systemically healthy male and female patients of age 20-55 yrs with Millers class I or class II gingival recession are included in the study.
Exclusion
- Patients who are medically compromised and Subjects who underwent radiotherapy or chemotherapy and who are Smokers are excluded from the study
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04375618
Start Date
October 1 2019
End Date
November 1 2021
Last Update
May 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
R V Chandra
Hyderabad, Telangana, India, 509002